Review



bottom chamber contained serum free rpmi sdf 1 cxcl12  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems bottom chamber contained serum free rpmi sdf 1 cxcl12
    Bottom Chamber Contained Serum Free Rpmi Sdf 1 Cxcl12, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 50 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+cxcl12/Recombinant+Human+CXCL12%2FSDF-1+gamma+Protein/pmc13592517-593-1-12
    Average 93 stars, based on 50 article reviews
    bottom chamber contained serum free rpmi sdf 1 cxcl12 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Expressing:

    Article Title: Unexpected diagnosis of WHIM syndrome in refractory autoimmune cytopenia
    Article Snippet: .. For this, cells expressing CXCR4 WT or mutants (1 × 10 5 cells per well) were stimulated with 100 nM recombinant human CXCL12 (rhCXCL12; R&D Systems) for 30, 60, 180, and 360 minutes at 37°C, 5% CO 2 . .. After incubation, cells were washed twice with staining buffer (phosphate buffered saline 10X [PBX] 1×/2% bovine serum albumin) and stained with anti-CXCR4-APC (BioLegend) for 30 minutes at 4°C.

    Recombinant:

    Article Title: Unexpected diagnosis of WHIM syndrome in refractory autoimmune cytopenia
    Article Snippet: .. For this, cells expressing CXCR4 WT or mutants (1 × 10 5 cells per well) were stimulated with 100 nM recombinant human CXCL12 (rhCXCL12; R&D Systems) for 30, 60, 180, and 360 minutes at 37°C, 5% CO 2 . .. After incubation, cells were washed twice with staining buffer (phosphate buffered saline 10X [PBX] 1×/2% bovine serum albumin) and stained with anti-CXCR4-APC (BioLegend) for 30 minutes at 4°C.

    Article Title: ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function
    Article Snippet: .. Recombinant human CXCL12 and CXCL14 were purchased from R&D systems (R&D Systems, Minneapolis, Minnesota, USA). .. ACKR3 agonist VUF11207 was obtained from Merck (Merck KGaA, Darmstadt, Germany).

    Article Title: Exosomal Galectin-3 Promotes Peritoneal Metastases in Gastric Adenocarcinoma via Microenvironment Alterations
    Article Snippet: .. For CXCL12 cross-inhibition of chemotaxis, recombinant human CXCL12 (R&D Systems, 350-NS) was loaded in the upper wells of a Boyden chamber plate (VWR), and the lower chambers were flowed in 240 mL of chemotaxis buffer with 1,000 ng/mL CXCL10 (R&D Systems, 266-IP). ..

    Article Title: ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function
    Article Snippet: .. Recombinant human CXCL12 and CXCL14 were purchased from R&D systems (R&D Systems, Minneapolis, Minnesota, USA). .. ACKR3 agonist VUF11207 was obtained from Merck (Merck KGaA, Darmstadt, Germany).

    Article Title: The tropomyosin 3.1/3.2 inhibitor ATM-3507 alters B-cell actin dynamics and impairs the growth and motility of diffuse large B-cell lymphoma cell lines
    Article Snippet: The cells were then added to a TranswellTM plate insert with 5-μm pores (Corning Life Sciences, Corning, NY, USA #3421). .. Imaging medium (600 μL) with the same concentration of ATM-3507 or DMSO plus 100 nM recombinant human CXCL12 (R&D Systems, Minneapolis, MN, USA #460-SD) was added to the bottom chamber. ..

    Article Title: Exosomal Galectin-3 promotes peritoneal metastases in gastric adenocarcinoma via microenvironment alterations
    Article Snippet: .. For CXCL12 cross-inhibition of chemotaxis, recombinant human CXCL12 (R&D Systems, 350-NS) was loaded in the upper wells of a Boyden chamber plate (VWR), and the lower chambers were flowed in 240 μL of chemotaxis buffer with 1,000 ng/mL CXCL10 (R&D Systems, 266-IP). ..

    Article Title: Transcriptomic signatures of cold acclimated adipocytes reveal CXCL12 as a Brown autocrine and paracrine chemokine
    Article Snippet: .. SH-SY5Y cells were differentiated as described above supplemented with 10 μM retinoic acid (Sigma Aldrich, Cat. R2625) or 0.01, 0.1 and 1 μM recombinant human CXCL12 (R&D Systems, Cat. 350-NS-050). .. SH-SY5Y cells were fixed in 4% PFA for 15 min before being incubated with permeabilization solution (0.5% Triton X-100, Sigma Aldrich, Cat. 93443) for 15 min. Nonspecific antibody binding was blocked with 3% BSA for 1 h at RT.

    Article Title: ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function.
    Article Snippet: .. Recombinant human CXCL12 and CXCL14 were purchased from R&D systems (R&D Systems, Minneapolis, Minnesota, USA). .. ACKR3 agonist VUF11207 was obtained from Merck (Merck KGaA, Darmstadt, Germany).

    Chemotaxis Assay:

    Article Title: Exosomal Galectin-3 Promotes Peritoneal Metastases in Gastric Adenocarcinoma via Microenvironment Alterations
    Article Snippet: .. For CXCL12 cross-inhibition of chemotaxis, recombinant human CXCL12 (R&D Systems, 350-NS) was loaded in the upper wells of a Boyden chamber plate (VWR), and the lower chambers were flowed in 240 mL of chemotaxis buffer with 1,000 ng/mL CXCL10 (R&D Systems, 266-IP). ..

    Article Title: Exosomal Galectin-3 promotes peritoneal metastases in gastric adenocarcinoma via microenvironment alterations
    Article Snippet: .. For CXCL12 cross-inhibition of chemotaxis, recombinant human CXCL12 (R&D Systems, 350-NS) was loaded in the upper wells of a Boyden chamber plate (VWR), and the lower chambers were flowed in 240 μL of chemotaxis buffer with 1,000 ng/mL CXCL10 (R&D Systems, 266-IP). ..

    Imaging:

    Article Title: The tropomyosin 3.1/3.2 inhibitor ATM-3507 alters B-cell actin dynamics and impairs the growth and motility of diffuse large B-cell lymphoma cell lines
    Article Snippet: The cells were then added to a TranswellTM plate insert with 5-μm pores (Corning Life Sciences, Corning, NY, USA #3421). .. Imaging medium (600 μL) with the same concentration of ATM-3507 or DMSO plus 100 nM recombinant human CXCL12 (R&D Systems, Minneapolis, MN, USA #460-SD) was added to the bottom chamber. ..

    Concentration Assay:

    Article Title: The tropomyosin 3.1/3.2 inhibitor ATM-3507 alters B-cell actin dynamics and impairs the growth and motility of diffuse large B-cell lymphoma cell lines
    Article Snippet: The cells were then added to a TranswellTM plate insert with 5-μm pores (Corning Life Sciences, Corning, NY, USA #3421). .. Imaging medium (600 μL) with the same concentration of ATM-3507 or DMSO plus 100 nM recombinant human CXCL12 (R&D Systems, Minneapolis, MN, USA #460-SD) was added to the bottom chamber. ..



    Similar Products

    94
    MedChemExpress recombinant human cxcl12
    Recombinant Human Cxcl12, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+cxcl12/SDF-1+alpha%2FCXCL12%2C+Human/pm42882462-108-3-7
    Average 94 stars, based on 1 article reviews
    recombinant human cxcl12 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress recombinant human sdf 1β cxcl12 protein
    Recombinant Human Sdf 1β Cxcl12 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+cxcl12/SDF-1+beta%2FCXCL12%2C+Human/pm42881250-116-9-13
    Average 94 stars, based on 1 article reviews
    recombinant human sdf 1β cxcl12 protein - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    R&D Systems bottom chamber contained serum free rpmi sdf 1 cxcl12
    Bottom Chamber Contained Serum Free Rpmi Sdf 1 Cxcl12, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+cxcl12/Recombinant+Human+CXCL12%2FSDF-1+gamma+Protein/pmc13592517-593-1-12
    Average 93 stars, based on 1 article reviews
    bottom chamber contained serum free rpmi sdf 1 cxcl12 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    MedChemExpress human cxcl12 recombinant protein
    Human Cxcl12 Recombinant Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+cxcl12/SDF-1+alpha%2FCXCL12%2C+Human/pm41987219-54-64-69
    Average 94 stars, based on 1 article reviews
    human cxcl12 recombinant protein - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    95
    R&D Systems cxcl12
    Cxcl12, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+cxcl12/Recombinant+Human%2FRhesus+Macaque%2FFeline+CXCL12%2FSDF-1+alpha/pm41941379-278-0-1
    Average 95 stars, based on 1 article reviews
    cxcl12 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    86
    Novoprotein recombinant human cxcl12
    Recombinant Human Cxcl12, supplied by Novoprotein, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+cxcl12/cxcl9+human+novoprotein+recombinant+s1148/pm41605906-159-0-7
    Average 86 stars, based on 1 article reviews
    recombinant human cxcl12 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    94
    R&D Systems stromal derived factor 1 beta
    Stromal Derived Factor 1 Beta, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+cxcl12/Recombinant+Human%2FFeline+CXCL12%2FSDF-1+beta+(aa+22-93)/pm41543936-808-34-42
    Average 94 stars, based on 1 article reviews
    stromal derived factor 1 beta - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    95
    R&D Systems sdf1
    Human Ad5E4ORF1 associates with scaffold proteins IQGAP1, DLG1, CASK, and LIN7C but only DLG1 promotes E4ORF1-mediated AKT activation . A , western blot analysis of Ad5E4ORF1 proteins and phosphorylated AKT and ERK1/2 in HUVECs. ( Top panel ) Cells infected with vector control or Ad5E4ORF1 viruses were starved for 4 h prior to cell lysis in LDS loading buffer. Tagged and untagged Ad5E4ORF1 proteins were probed with Ad5E4ORF1-, Flag-, or HA-specific antibodies. VCN ( bottom ), genomic lentiviral vector copy numbers. ( Lower panels ) Densitometry quantification of immunoblots shown in the top panel . Phosphorylated AKT and ERK signals were normalized to their respective total protein levels and expressed relative to the vector control, which was set to 1. Ad5E4ORF1 protein levels, normalized to GAPDH, were quantified from anti-Ad5E4ORF1 immunoblots and expressed relative to native (untagged) E4ORF1. Data are presented as mean ± SD from 3 to 5 independent HUVEC lines. Statistical analysis was performed using one-way ANOVA (two-sided), followed by Tukey’s post hoc test. ns, nonsignificant; ∗, p < 0.05; ∗∗, p < 0.01; ∗∗∗, p < 0.001; ∗∗∗∗, p < 0.0001 ( p value notation used throughout all figures). B , Ad5E4ORF1-enabled cell survival under starvation. Indicated transduced HUVECs were kept in minimal X-Vivo 20 medium for 7 days and cell survival rates (percentage of live cells in starvation relative to those in growth medium) presented as mean ± SD. One-way ANOVA with Tukey’s test (n = 3 independent HUVEC lines). C , identification of Ad5E4ORF1-interacting proteins in HUVECs. Cells expressing GFP (−) or Flag-Ad5E4ORF1 (+) were subjected to cross-linking anti-Flag immunoprecipitation. Flag peptide-eluted proteins were resolved on SDS-PAGE and gel slices analyzed by mass spectrometric protein ID. Shown is an SDS-PAGE silver stain with major identified candidate proteins marked on the right. The band corresponding to LIN7C was identified based on increased signal intensity over a comigrating background protein, denoted by an asterisk (∗). D , confirmation of identified interactions by protein immunoprecipitation (IP) in HUVECs expressing HA-tagged wild type (WT) or mutant Ad5E4ORF1. ΔC3, deletion of C terminal 3 amino acids (part of PDZ-binding motif). Whole cell lysates were prepared in IGEPAL CA-630 buffer without cell cross-linking. Bead-bound proteins, along with 15% of the corresponding input lysates, were analyzed by western blot. Data shown represent experiments using three HUVEC lines. E , interdependence of Ad5E4ORF1 scaffold interactions. DLG1, CASK, or LIN7C gene-specific shRNAs or a nontargeting (NT) shRNA were stably expressed under doxycycline induction for 4 days in control and HA-Ad5E4ORF1-transduced HUVECs. ( Left panel ) Immunoprecipitation blot performed as in ( D ). ( Right panels ) Densitometry quantification of DLG1, CASK, and LIN7C IP efficiency (IP/Input) in gene knockdown (KD) HUVECs relative to NT control. One-way ANOVA with Tukey’s test (mean ± SD; n = 3 HUVEC lines). F , schematic model of Ad5E4ORF1 interactions with scaffold proteins. G and H , effect of scaffold protein knockdowns on AKT activation. Indicated gene-specific shRNAs were doxycycline-induced for 4 days in HUVECs, which were then starved for 4 h and subjected to western blot analysis. Data shown represent experiments using three HUVEC lines. ( H , lower panel ) Quantification of AKT phosphorylation (average of two shRNAs) from upper panel blots. One-way ANOVA with Tukey’s test (mean ± SD; n = 3 HUVEC lines). I , effect of DLG1 knockdown on receptor-mediated AKT activation. DLG1-specific (+) and nontargeting (NT) shRNAs were doxycycline-induced in HUVECs for 4 days. After 4 h of starvation, cells were stimulated for 5 min with the indicated cytokines (20 ng/ml FGF2, HGF, <t>SDF1;</t> or 100 nM S1P) and lysed directly into LDS loading buffer for western blot. ( Lower panels ) Quantification of AKT and ERK phosphorylation from upper panel blots. Paired t test (mean ± SD; n = 3 HUVEC lines). Ad5E4ORF1, human adenovirus serotype 5 early gene E4ORF1; AKT, protein kinase B; CASK, calcium/calmodulin-dependent serine protein kinase; DLG1, discs large homolg 1; ERK, extracellular signal-regulated kinase; FGF2, fibroblast growth factor 2; HGF, hepatocyte growth factor; HUVEC, human umbilical vein endothelial cells; IQGAP1, IQ motif containing GTPase activating protein 1; LDS, lithium dodecyl sulfate; LIN7C, Lin-7 Cell Polarity Scaffold C; SDF1, stromal cell-derived factor-1; VCN, viral copy number.
    Sdf1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+cxcl12/Recombinant+Human%2FRhesus+Macaque%2FFeline+CXCL12%2FSDF-1+alpha/pmc12743444-341-5-6
    Average 95 stars, based on 1 article reviews
    sdf1 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    Image Search Results


    Human Ad5E4ORF1 associates with scaffold proteins IQGAP1, DLG1, CASK, and LIN7C but only DLG1 promotes E4ORF1-mediated AKT activation . A , western blot analysis of Ad5E4ORF1 proteins and phosphorylated AKT and ERK1/2 in HUVECs. ( Top panel ) Cells infected with vector control or Ad5E4ORF1 viruses were starved for 4 h prior to cell lysis in LDS loading buffer. Tagged and untagged Ad5E4ORF1 proteins were probed with Ad5E4ORF1-, Flag-, or HA-specific antibodies. VCN ( bottom ), genomic lentiviral vector copy numbers. ( Lower panels ) Densitometry quantification of immunoblots shown in the top panel . Phosphorylated AKT and ERK signals were normalized to their respective total protein levels and expressed relative to the vector control, which was set to 1. Ad5E4ORF1 protein levels, normalized to GAPDH, were quantified from anti-Ad5E4ORF1 immunoblots and expressed relative to native (untagged) E4ORF1. Data are presented as mean ± SD from 3 to 5 independent HUVEC lines. Statistical analysis was performed using one-way ANOVA (two-sided), followed by Tukey’s post hoc test. ns, nonsignificant; ∗, p < 0.05; ∗∗, p < 0.01; ∗∗∗, p < 0.001; ∗∗∗∗, p < 0.0001 ( p value notation used throughout all figures). B , Ad5E4ORF1-enabled cell survival under starvation. Indicated transduced HUVECs were kept in minimal X-Vivo 20 medium for 7 days and cell survival rates (percentage of live cells in starvation relative to those in growth medium) presented as mean ± SD. One-way ANOVA with Tukey’s test (n = 3 independent HUVEC lines). C , identification of Ad5E4ORF1-interacting proteins in HUVECs. Cells expressing GFP (−) or Flag-Ad5E4ORF1 (+) were subjected to cross-linking anti-Flag immunoprecipitation. Flag peptide-eluted proteins were resolved on SDS-PAGE and gel slices analyzed by mass spectrometric protein ID. Shown is an SDS-PAGE silver stain with major identified candidate proteins marked on the right. The band corresponding to LIN7C was identified based on increased signal intensity over a comigrating background protein, denoted by an asterisk (∗). D , confirmation of identified interactions by protein immunoprecipitation (IP) in HUVECs expressing HA-tagged wild type (WT) or mutant Ad5E4ORF1. ΔC3, deletion of C terminal 3 amino acids (part of PDZ-binding motif). Whole cell lysates were prepared in IGEPAL CA-630 buffer without cell cross-linking. Bead-bound proteins, along with 15% of the corresponding input lysates, were analyzed by western blot. Data shown represent experiments using three HUVEC lines. E , interdependence of Ad5E4ORF1 scaffold interactions. DLG1, CASK, or LIN7C gene-specific shRNAs or a nontargeting (NT) shRNA were stably expressed under doxycycline induction for 4 days in control and HA-Ad5E4ORF1-transduced HUVECs. ( Left panel ) Immunoprecipitation blot performed as in ( D ). ( Right panels ) Densitometry quantification of DLG1, CASK, and LIN7C IP efficiency (IP/Input) in gene knockdown (KD) HUVECs relative to NT control. One-way ANOVA with Tukey’s test (mean ± SD; n = 3 HUVEC lines). F , schematic model of Ad5E4ORF1 interactions with scaffold proteins. G and H , effect of scaffold protein knockdowns on AKT activation. Indicated gene-specific shRNAs were doxycycline-induced for 4 days in HUVECs, which were then starved for 4 h and subjected to western blot analysis. Data shown represent experiments using three HUVEC lines. ( H , lower panel ) Quantification of AKT phosphorylation (average of two shRNAs) from upper panel blots. One-way ANOVA with Tukey’s test (mean ± SD; n = 3 HUVEC lines). I , effect of DLG1 knockdown on receptor-mediated AKT activation. DLG1-specific (+) and nontargeting (NT) shRNAs were doxycycline-induced in HUVECs for 4 days. After 4 h of starvation, cells were stimulated for 5 min with the indicated cytokines (20 ng/ml FGF2, HGF, SDF1; or 100 nM S1P) and lysed directly into LDS loading buffer for western blot. ( Lower panels ) Quantification of AKT and ERK phosphorylation from upper panel blots. Paired t test (mean ± SD; n = 3 HUVEC lines). Ad5E4ORF1, human adenovirus serotype 5 early gene E4ORF1; AKT, protein kinase B; CASK, calcium/calmodulin-dependent serine protein kinase; DLG1, discs large homolg 1; ERK, extracellular signal-regulated kinase; FGF2, fibroblast growth factor 2; HGF, hepatocyte growth factor; HUVEC, human umbilical vein endothelial cells; IQGAP1, IQ motif containing GTPase activating protein 1; LDS, lithium dodecyl sulfate; LIN7C, Lin-7 Cell Polarity Scaffold C; SDF1, stromal cell-derived factor-1; VCN, viral copy number.

    Journal: The Journal of Biological Chemistry

    Article Title: Adenovirus E4ORF1 activates isoform-specific phosphatidylinositol 3-kinase signaling in human endothelial cells

    doi: 10.1016/j.jbc.2025.110947

    Figure Lengend Snippet: Human Ad5E4ORF1 associates with scaffold proteins IQGAP1, DLG1, CASK, and LIN7C but only DLG1 promotes E4ORF1-mediated AKT activation . A , western blot analysis of Ad5E4ORF1 proteins and phosphorylated AKT and ERK1/2 in HUVECs. ( Top panel ) Cells infected with vector control or Ad5E4ORF1 viruses were starved for 4 h prior to cell lysis in LDS loading buffer. Tagged and untagged Ad5E4ORF1 proteins were probed with Ad5E4ORF1-, Flag-, or HA-specific antibodies. VCN ( bottom ), genomic lentiviral vector copy numbers. ( Lower panels ) Densitometry quantification of immunoblots shown in the top panel . Phosphorylated AKT and ERK signals were normalized to their respective total protein levels and expressed relative to the vector control, which was set to 1. Ad5E4ORF1 protein levels, normalized to GAPDH, were quantified from anti-Ad5E4ORF1 immunoblots and expressed relative to native (untagged) E4ORF1. Data are presented as mean ± SD from 3 to 5 independent HUVEC lines. Statistical analysis was performed using one-way ANOVA (two-sided), followed by Tukey’s post hoc test. ns, nonsignificant; ∗, p < 0.05; ∗∗, p < 0.01; ∗∗∗, p < 0.001; ∗∗∗∗, p < 0.0001 ( p value notation used throughout all figures). B , Ad5E4ORF1-enabled cell survival under starvation. Indicated transduced HUVECs were kept in minimal X-Vivo 20 medium for 7 days and cell survival rates (percentage of live cells in starvation relative to those in growth medium) presented as mean ± SD. One-way ANOVA with Tukey’s test (n = 3 independent HUVEC lines). C , identification of Ad5E4ORF1-interacting proteins in HUVECs. Cells expressing GFP (−) or Flag-Ad5E4ORF1 (+) were subjected to cross-linking anti-Flag immunoprecipitation. Flag peptide-eluted proteins were resolved on SDS-PAGE and gel slices analyzed by mass spectrometric protein ID. Shown is an SDS-PAGE silver stain with major identified candidate proteins marked on the right. The band corresponding to LIN7C was identified based on increased signal intensity over a comigrating background protein, denoted by an asterisk (∗). D , confirmation of identified interactions by protein immunoprecipitation (IP) in HUVECs expressing HA-tagged wild type (WT) or mutant Ad5E4ORF1. ΔC3, deletion of C terminal 3 amino acids (part of PDZ-binding motif). Whole cell lysates were prepared in IGEPAL CA-630 buffer without cell cross-linking. Bead-bound proteins, along with 15% of the corresponding input lysates, were analyzed by western blot. Data shown represent experiments using three HUVEC lines. E , interdependence of Ad5E4ORF1 scaffold interactions. DLG1, CASK, or LIN7C gene-specific shRNAs or a nontargeting (NT) shRNA were stably expressed under doxycycline induction for 4 days in control and HA-Ad5E4ORF1-transduced HUVECs. ( Left panel ) Immunoprecipitation blot performed as in ( D ). ( Right panels ) Densitometry quantification of DLG1, CASK, and LIN7C IP efficiency (IP/Input) in gene knockdown (KD) HUVECs relative to NT control. One-way ANOVA with Tukey’s test (mean ± SD; n = 3 HUVEC lines). F , schematic model of Ad5E4ORF1 interactions with scaffold proteins. G and H , effect of scaffold protein knockdowns on AKT activation. Indicated gene-specific shRNAs were doxycycline-induced for 4 days in HUVECs, which were then starved for 4 h and subjected to western blot analysis. Data shown represent experiments using three HUVEC lines. ( H , lower panel ) Quantification of AKT phosphorylation (average of two shRNAs) from upper panel blots. One-way ANOVA with Tukey’s test (mean ± SD; n = 3 HUVEC lines). I , effect of DLG1 knockdown on receptor-mediated AKT activation. DLG1-specific (+) and nontargeting (NT) shRNAs were doxycycline-induced in HUVECs for 4 days. After 4 h of starvation, cells were stimulated for 5 min with the indicated cytokines (20 ng/ml FGF2, HGF, SDF1; or 100 nM S1P) and lysed directly into LDS loading buffer for western blot. ( Lower panels ) Quantification of AKT and ERK phosphorylation from upper panel blots. Paired t test (mean ± SD; n = 3 HUVEC lines). Ad5E4ORF1, human adenovirus serotype 5 early gene E4ORF1; AKT, protein kinase B; CASK, calcium/calmodulin-dependent serine protein kinase; DLG1, discs large homolg 1; ERK, extracellular signal-regulated kinase; FGF2, fibroblast growth factor 2; HGF, hepatocyte growth factor; HUVEC, human umbilical vein endothelial cells; IQGAP1, IQ motif containing GTPase activating protein 1; LDS, lithium dodecyl sulfate; LIN7C, Lin-7 Cell Polarity Scaffold C; SDF1, stromal cell-derived factor-1; VCN, viral copy number.

    Article Snippet: Other cytokines: HGF (PeproTech 100–39H); SDF1 (R&D Systems 350-NS); and S1P (Sigma-Aldrich 73914).

    Techniques: Activation Assay, Western Blot, Infection, Plasmid Preparation, Control, Lysis, Expressing, Immunoprecipitation, SDS Page, Silver Staining, Mutagenesis, Binding Assay, shRNA, Stable Transfection, Knockdown, Phospho-proteomics, Derivative Assay